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Microvesicles were isolated from the conditioned media of 3 cell lines (MDA-MB-231, AsPC-1 and A375) by
ultracentrifugation at a range of relative centrifugal forces, and the tissue factor (TF) protein and activity,
microvesicle number, size distribution and relative density compared. Also, by expressing TF-tGFP in cells
and isolating the microvesicles, the relative density of TF-containing microvesicles was established.
Nanoparticle tracking analysis (NTA) indicated that the larger-diameter microvesicles (200 nm) were
primarily sedimented at 100,000g and possessed TF-dependent thrombin and factor Xa generation potential,
while in the absence of factor VII, all microvesicles possessed some thrombin generation capacity. Immuno-
precipitation of TF-containing microvesicles followed by NTA also indicated the range of these microvesicles
to be 200400 nm. Analysis of the microvesicles by gradient density centrifugation showed that lower-density
(B1.1 g/ml) microvesicles were mainly present in the samples recovered at 100,000g and were associated with
TF antigen and activity. Analysis of these fractions by NTA confirmed that these fractions were principally
composed of the larger-diameter microvesicles. Similar analysis of microvesicles from healthy or patient
plasma supported those obtained from conditioned media indicating that TF activity was mainly associated
with lower-density microvesicles. Furthermore, centrifugation of healthy plasma, supplemented with TF-
tGFP-containing microvesicles, resulted in 67% retrieval of the fluorescent microvesicles at 100,000g, but only
26% could be recovered at 20,000g. Pre-centrifugation of conditioned media or plasma at 10,000g improved
the speed and yield of recovered TF-containing microvesicles by subsequent centrifugation at either 20,000g
or 100,000g. In conclusion, TF appears to be associated with low-density (1.031.08 g/ml), larger-diameter
(200350 nm) microvesicles.
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M
icrovesicles are phospholipid vesicles which
range in diameter from below 100 nm to
around 700 nm, although a recent study has
reported these to be at the lower end of this range (1).
Microvesicles are released from cells following cellular
activation and contain proteins, lipids and nucleic acids
derived from the parent cell. Increased levels of tissue
factor (TF)positive microvesicles have been detected in
the plasma of patients with various chronic diseases
compared to healthy individuals (2,3). Elevation in
procoagulant microvesicles is linked with hypercoagul-
ability and increased risk of thrombosis (3). As such, the
relevance of measurement and examination of procoagu-
lant microvesicles to the understanding of the mechan-
isms of regulation of haemostasis and the induction of
coagulation during pathological condition is conspicuous.
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Whereas the measurement of microvesicles is often
carried out while still within plasma, enrichment of the
microvesicles permits the examination of physical and bio-
chemical properties of the microvesicles which otherwise
cannot be determined accurately due to contamination.
Moreover, although there are guidelines for the pre-
analytical variables recommended for the preparation
of microvesicle samples (4,5), currently there are no clear
protocols for the preparation of microvesicles (5) for the
purpose of examination of the associated procoagulant
activity. It is clear that even microvesicles derived from
1 type of cell do not constitute a homogeneous popula-
tion and differ widely in their source of origin within the
cell and, consequently, protein and lipid composition as
well as physical properties (6). It has been suggested that
discrepancies in the reported properties of microvesicles
may arise as a consequence of laboratory practices during
the preparation of microvesicles (7). A common means
of microvesicle purification and enrichment involves the
sedimentation of microvesicles by ultracentrifugation.
However, since procedures described by various labo-
ratories use different centrifugal forces to sediment the
microvesicles, it is also evident that the optimal centrifu-
gation speed for the sedimentation of all populations of
microvesicles has not yet been determined (5). Previously,
we reported that the majority of TF antigen appeared to
be associated with microvesicles of larger diameter which
were recoverable at higher centrifugal forces (8). In this
study, we have further examined the properties of the TF-
containing microvesicles isolated from conditioned media
of 3 cell lines. In addition, we have assessed the influence
of centrifugal force on the efficiency of the recovery of
microvesicles and particularly TF-containing microvesi-
cles. Furthermore, gradient density ultracentrifugation
techniques have previously been used to determine the
relative density of exosomes (9,10). Similar techniques were
used here to establish the relative density of microvesicle
fractions recovered from conditioned media, as well as
from samples of healthy and patient plasma. In addition,
by expressing a TF-tGFP hybrid protein in the cells
prior to microvesicle purification, we have established the
relative density and size of TF-containing microvesicles.
Material and methods
Cell culture, transfection and microvesicle
purification
Human breast cancer cell line MDA-MB-231 and human
melanoma cells A375 (ATCC, Teddington, UK) were
cultured in DMEM (Lonza, Cambridge, UK) contain-
ing foetal calf serum 10% (v/v; Source Bioscience plc,
Nottingham, UK). Human pancreatic (ascites meta) cell
line AsPC-1 (ATCC) was cultured in RPMI-1640 (Lonza)
containing foetal calf serum 10% (v/v). These 3 cell lines
are capable of expressing and releasing bursts of high
levels of TF as microvesicles following activation. Cells
were cultured in 75 cm2 flasks until 80% confluent prior
to microvesicle preparation. Cells were washed and pre-
adapted to respective serum-free medium prior to acti-
vation and harvesting of conditioned media. To induce
microvesicle release, the cells were stimulated with PAR2-
activating peptide (PAR2-AP); SLIGRL (20 mM) (Sigma
Chemical Company, Poole, UK) for 30 min according
to published procedures (1113). The conditioned media
were cleared of any cell debris by centrifuging for 10 min
at 5,400g on a microcentrifuge. The samples (1 ml aliquots)
were then placed in 1134 mm polycarbonate centrifuge
tubes (Beckman Coulter, High Wycombe, UK), and
the cell-derived microvesicles were sedimented at various
relative centrifugal forces (RCF) ranging from 20,000 to
150,000g on a TL-100 ultracentrifuge at 208C, using a
TLA 100.2 rotor (Beckman) for 1 h, as described in Ref.
(11). In some experiments, the denser microvesicles were
first removed by centrifugation at 10,000g for 1 h prior
to sedimentation at the above RCF. All isolated micro-
vesicles were then resuspended in pre-filtered (0.1 mm)
PBS (200 ml). Previous analysis of the microvesicles for
the exosome markers Tsg101 and CD9 by western blot
examination revealed that exosomes were absent, which
was likely to be due to the short incubation times (8,11).
To demonstrate this further, exosomes were immuno-
precipitated using either anti-Tsg101 antibody or CD9
(Gentex/Source Bioscience, Nottingham, UK), followed
by protein A-magnetic beads. The samples were tested
for TF antigen by enzyme immunoassay (EIA), as below.
In some experiments, MDA-MB-231 cells were cultured in
25 cm2 flasks and transfected with pCMV-AC-TF-tGFP
(Origene, Rockville, MD, USA), which encodes for turbo-
GFP (tGFP) in tandem, on the C-terminal of TF. DNA
transfection was performed using Lipofectin (Invitrogen,
Paisley, UK), as previously described (1114). Transfec-
tion of MDA-MB-231 cells resulted in a marginal increase
in TF antigen and activity. However, due to the nature
of these cells, the amount of TF within the cells is
moderated (15). Cells were permitted to express TF-
tGFP for 48 h, and microvesicles were isolated from the
conditioned media at 20,000g and 100,000g, as described
in this article. The transfection efficiency into MDA-
MB-231 cells was typically 63%912, and the TF-tGFP
possessed similar TFactivity to unconjugated TF, in agree-
ment with our previous data (8). Microvesicles were also
recovered from the plasma of diseased (colorectal cancer
and cardiovascular patients) or normal subjects (Innovative
Research, Novi, MI, USA) (11) and used in some
experiments. Finally, citrated normal human plasma was
supplemented with isolated microvesicles containing TF-
tGFP, in PBS (50 ml), prepared as above, without clot
formation. The plasma and the fluorescent microvesicles
were centrifuged at 20,000g and 100,000g at 208C for 1 h, as
described in this article, and the microvesicles resuspended
Camille Ettelaie et al.
2
(page number not for citation purpose)
Citation: Journal of Extracellular Vesicles 2014, 3: 23592 - http://dx.doi.org/10.3402/jev.v3.23592
in the original volume of 50ml of PBS. The fluorescence emis-
sions of the recovered samples were measured at 510 nm
and compared to the original samples before centrifugation.
Analysis of microvesicle numbers and size
distribution
The numbers and size distributions of the isolated
microvesicles were determined by nanoparticle tracking
analysis (NTA) using NanoSight LM10 and NTA soft-
ware (NanoSight Ltd, Amesbury, UK). The NanoSight
instrument was calibrated using FluoSpheres† carboxylate-
modified microspheres with diameters of 0.02, 0.1 and
1.0 mm (Invitrogen). The lower limit of detection was
determined to be between 0.02 and 0.1 mm. MV samples
were diluted 1:10 in 0.1 mm-filtered PBS and analysed
by tracking particles over 90s using a camera level of
12 and shutter speed of 23.22 frames/s, as described in
Ref. (14). Data were analysed using the NTA software
to determine the concentration and size distribution of
the microvesicles. In order to quantify the distribution
of the microvesicles, the traces obtained from NTA were
separated (according to the main peaks observed) into
3 classes with diameters of B100 nm (small), 100250
nm (medium) and 250 nm (large size), and the number
of microvesicles within each group determined.
Analysis of microvesicle-associated TF antigen and
activity
TF antigen content of the microvesicles was determined
using a TF-antigen EIA kit (Enzyme Research Labora-
tories Ltd, Swansea, UK), as described in Refs. (1115).
Microvesicle-associated thrombin generation potential of
the samples was measured using a chromogenic thrombin
generation assay, as described in Refs. (1115), and the
absorptions were measured at 410 nm on a spectro-
photometer. In order to distinguish between TF-mediated
and TF-independent thrombin generation, thrombin gen-
eration activities were also compared in the presence
of normal and factor VIIdeficient plasma and also in
the presence of an inhibitory anti-TF antibody (HTF-1;
Affymatrix eBioscience, Hatfield, UK). The potential for
factor Xa generation was assessed using the Actichrome
TF activity assay kit (American Diagnostica/Invitech Ltd,
Molesworth, UK) in the presence and absence of factor
VII as described before (15), and the absorptions were
measured at 410 nm on a spectrophotometer.
Examination of the relative density of the
microvesicles by density gradient centrifugation
Microvesicles were analysed by density gradient ultra-
centrifugation using a sucrose-OptiPrep (PROGEN
Biotechnik GmbH, Heidelberg, Germany) gradient ac-
cording to the manufacturer’s instructions. A 50% (w/v)
working solution (WS) was prepared by mixing a solution
of 0.25 M sucrose, 6 mM EDTA and 60 mM Tris-HCl
pH7.4 with OptiPrep at a ratio of 1:5 (v:v). Prior to the
experiments, the stability of the microvesicles in EDTA
solutions was examined by analysing the NTA profiles,
and was shown to remain unaffected at least up to 5 mM
EDTA (Supplementary Fig. 1). Two solutions representing
the top and the bottom concentration of sucroseOptiPrep
were prepared by mixing the WS with dilution buffer
(DB) (0.25 M sucrose, 1 mM EDTA and 10 mM Tris-HCl
pH7.4) at WS:DB ratios of 1:15.7 and 24:1 (v:v), respec-
tively. The microvesicle samples (100 ml in PBS) were mixed
with the Optiprep at a ratio of 1:5 (v/v) and were in turn
placed at the bottom of 1489 mm Ultra-clear centrifuge
tubes (Beckman Coulter). A density gradient was then
prepared using the top and bottom sucroseOptiprep
solutions covering an approximate density range of 1.02
1.22 g/ml. To ensure accuracy, 2 separate sets of Density-
MarkerBeads (Amersham Pharmacia Biotech, Uppsala,
Sweden) were loaded in 2 separate tubes and centrifuged
alongside. The samples and markers were placed in a
SW41Ti swing-out rotor and centrifuged at 52,000g
for 90 min at 208C on a Beckman L8-M ultracentrifuge
(Beckman Coulter). Following centrifugation, aliquots
(0.5 ml) were sequentially removed from the top of the
tube, ensuring that the formed gradient was not disrupted.
As a guide, the distribution of the microvesicles within
the samples was analysed by measuring the protein content
by Bradford assay and subtracted from a similar set but
without any sample loaded. A density standard curve was
then prepared using the 2 sets of markers from which the
density of the various sample fractions was then deter-
mined. In some experiments, the amount of TF protein
and the thrombin generation potential of each fraction
were assessed using the chromogenic thrombin generation
assay. Additionally, the presence of TF-tGFP-containing
microvesicles was determined by measuring the fluores-
cence emission of GFP at 510 nm and subtracting the
emission of similar fractions prepared from microvesicles
from untransfected MDA-MB-231 cells. In order to analyse
the TF content of fractions prepared from microvesicle
samples derived from healthy and diseased plasma, the
fractions (200 ml) were adsorbed onto annexin vcoated
plates (Hyphen Biomed/Quadratech Ltd, Epsom, UK),
washed and the thrombin generation potential measured
in the presence and the absence of factor VII. Finally, frac-
tions containing significant amounts of TF were pooled and
the size of the microvesicle population analysed by NTA.
TF-containing microvesicles were also isolated directly
from conditioned media of MDA-MB-231 and A375 cell
lines, by immuno-precipitation using a monoclonal anti-
body against TF (10H10) (Santa Cruz Biotechnology,
Heidelberg, Germany), followed by protein A magnetic
beads (Miltenyi Biotec, Bisley, UK). The microvesicles
were released in phosphate buffer (10 mM) pH 7.4,
containing NaCl (500 mM). Controls without the anti-
body were included. The size distribution of the micro-
vesicles was then assessed by NTA.
Properties of TF-containing microparticles
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Determination of the density of the media and
plasma
Since sedimentation of microvesicles is also dependent
on the density of the supporting media, the density of the
media or plasma prior to centrifugation was measured
by accurately measuring the weight of a precise volume
(1 ml) of each fluid. Subsequent to centrifugation, the
density of the top and bottom 100 ml fractions were also
determined by weighing.
Results
Analysis of the TF protein and activity in microvesicles
purified by sedimentation at various RCF
Analysis of the microvesicle samples prepared by ultra-
centrifugation at 100,000g showed at least a 2-fold
increase in the amount of TF antigen content compared
to samples sedimented at lower centrifugal forces (Fig.
1A), and it was highest in the sample isolated from AsPC-1
cells. In agreement with the amount of TF antigen, the
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Fig. 1. Analysis of TF antigen and activity associated with microvesicles isolated at various RCF. Cell lines (AsPC-1, MDA-MB-231
and A375) were washed and pre-adapted to respective serum-free media prior to activation with PAR2-AP (SLIGRL; 20 mM). The
conditioned media were collected and cleared of any cell debris by centrifuging at 5,400g for 10 min on a microcentrifuge. Cell-derived
microvesicles were then sedimented at various RCF ranging from 20,000 to 100,000g at 208C for 1 h. (A) TF antigen content of the
recovered microvesicles was determined using a TF-specific EIA assay (n3, *pB0.05 vs. respective values recovered at 20,000g).
TF-dependent and TF-independent thrombin generation potential of the fractions was assessed using a chromogenic thrombin
generation assay in the presence (B) and absence of factor VII (C), respectively, by measuring the absorption at 410 nm (n3,
*pB0.05 vs. respective values recovered at 20,000g). In addition, TF-dependent and TF-independent factor Xa generation potential
of the samples was analysed using the Actichrome TF-activity assay in the presence (D) and absence of factor VII (E), respectively, by
measuring the absorption at 410 nm (n3, *pB0.05 vs. respective values recovered at 20,000g). (F) Samples of microvesicles were
isolated at various RCF ranging from 20,000 to 100,000g at 208C for 1 h from the media of the MDA-MB-231 cell line and were pre-
incubated with an inhibitory anti-TF antibody (HTF-1) prior to analysing the thrombin generation potential (n3).
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thrombin generation activity was highest in samples
recovered at 100,000g. However, the values for the
thrombin generation (measured as absorption at 410 nm)
did not reflect the magnitude of the differences in TF
antigen, observed between the procedures of ultracentri-
fugation (Fig. 1B). In fact, analysis of the thrombin
generation associated with the microvesicles, in the ab-
sence of factor VII, indicated the presence of some
TF-independent thrombin generation potential in all of
the samples (Fig. 1C). Analysis of the samples using a
factor Xa generation assay, in the presence and absence
of factor VIIa, produced a better representation of the
measured levels of TF antigen associated with the micro-
vesicles (Fig. 1D and E). These data were also confirmed
by the inhibition of TF activity using the HTF-1 anti-
body (Fig. 1F). None of the isolated samples contained
detectable amounts of CD9 or Tsg101 (Supplementary
Fig. 2), as demonstrated in Refs. (8,11,14). Furthermore,
depletion of the samples by immunoprecipitation with
anti-Tsg101 or CD9 did not precipitate any detectable
microvesicles, or TF antigen (Supplementary Fig. 3), and
did not alter the amount of TF antigen in the supernatant.
Furthermore, adsorption of the microvesicles onto annex-
in v resulted in the retention of all of the TF activity on
the plate with no further activity detected in the super-
natant, indicating that the TF was associated with micro-
vesicles only (Supplementary Fig. 4).
Analysis of the number and size distribution of
microvesicles purified by sedimentation at various RCF
Analysis of the concentration of microvesicles by NTA
showed enhancement of the efficiency of total microvesicle
recovery with increasing centrifugal forces up to 100,000g
(Fig. 2A), but no significant advantage was detected
at 150,000g (not shown). Moreover, in this study
(Supplementary Fig. 5) and also in Ref. (14), we have
shown that both the number and the size distribution
of the microvesicles recovered at 100,000g were closely
comparable to those observed in pre-centrifuged condi-
tioned media. Therefore, the possibilities of the pro-
duction of artefacts through microvesicle break-up, or
alternatively microvesicle merger, as a consequence of
ultracentrifugation may be discounted. Additionally, the
use of fresh serum-free medium, the short incubation
time (30 min), and the initial sedimentation using the
microcentrifuge explain the lack of any observable mem-
brane debris or protein aggregates. Analysis of the size
distribution of the microvesicles, recovered at various
centrifugal forces, showed a narrower range at 20,000g
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Fig. 2. Analysis of the number of microvesicles isolated at various RCF. Cell lines (AsPC-1, MDA-MB-231 and A375) were washed and
pre-adapted to respective serum-free media prior to activation with PAR2-AP (SLIGRL; 20 mM). The conditioned media were collected
and cleared of any cell debris by centrifuging at 5,400g for 10 min on a microcentrifuge. Cell-derived microvesicles were then
sedimented at various RCF ranging from 20,000 to 100,000g. (A) Total number of microvesicles was determined using NTA (n6,
*pB0.05 vs. respective values recovered at 20,000g). The traces from each analysis (samples shown in Supplementary Fig. 5) were
then divided into 3 sections representing microvesicles with diameters of B100 nm, 100250 nm and 250 nm. The number of
microvesicles within each group were then determined for (B) AsPC-1, (C) MDA-MB-231 and (D) A375 cells (n9, *pB0.05 vs.
respective values recovered at 20,000g).
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which became wider with the increasing centrifugal force
used (Supplementary Fig. 5). In order to quantify the
distribution of the microvesicles, the traces obtained from
the NTA were separated into 3 classes according to the
main peaks observed. These 3 groups were designated
as smaller-sized (diameters of B100 nm), medium-sized
(100250 nm) and larger-sized (250 nm) microvesicles.
Subsequently, the number of microvesicles in each size
group, recovered at each centrifugal force, was determined
for each of the 3 cell lines (Fig. 2BD). Analysis of these
distributions of MDA-MB-231-derived and A375-derived
microvesicles showed progressive enhancement of the re-
covery of medium-sized microvesicles with increasing
centrifugal force. Some enrichment of the population of
smaller-sized microvesicles was achievable at centrifugal
forces of 75,000g or higher, although the media of A375
cells did not contain a large proportion of this group of
microvesicles. Separation of the larger-sized microvesicles
from MDA-MB-231 and AsPC-1 cells required centrifu-
gation at 100,000g, but limited recovery from A375 cells
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Fig. 3. Analysis of the relative density of microvesicles by density gradient centrifugation. Cells lines (MDA-MB-231 and A375) were
washed and pre-adapted to respective serum-free media prior to activation with PAR2-AP (SLIGRL; 20 mM). The conditioned media
were collected and cleared of any cell debris by centrifuging at 5,400g for 10 min on a microcentrifuge. Cell-derived microvesicles were
then sedimented at various RCF ranging from 20,000 to 100,000g at 208C for 1 h. Microvesicles recovered at various centrifugal forces
were analysed by density gradient ultracentrifugation using a sucroseOptiPrep gradient covering an approximate range of 1.021.22 g/
ml against 2 sets of DensityMarkerBeads as density markers. The samples and markers were centrifuged at 52,000g for 90 min at 208C.
The distribution of the protein content of the microvesicles derived from (A) MDA-MB-231 and (B) A375 cells was analysed using the
Bradford assay, by measuring the absorption at 584 nm and subtracting the values obtained from a similar set without loading the
microvesicles. Traces were obtained by calculating the moving-average values calculated from the data.
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was possible at 75,000g. The number of APSC-1-derived
microvesicles was significantly higher in all 3 size groups.
Density gradient centrifugation of the purified
microvesicles and analysis of the protein distribution
To analyse the distribution of the relative density of the
microvesicles recovered at different centrifugal forces,
the samples prepared from the conditioned media of
MDA-MB-231 and A375 cells were fractionated by
sucroseOptiPrep density gradient centrifugation. Frac-
tions (0.5 ml) were in turn removed from the top of the
tube, and the relative amount of protein in the fractions
estimated by Bradford assay and subtracted from a
similar set without loading the microvesicles. Analysis
of total protein concentration, in the fractions from
both MDA-MB-231 and A375 cell lines, indicated the
presence of microvesicles in all fractions with relative
densities of 1.1 g/ml (Fig. 3A and B). Furthermore,
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Fig. 4. Analysis of the TF antigen content and thrombin generation potential of microvesicle fractions separated by density gradient
centrifugation. MDA-MB-231 cells were washed and pre-adapted to respective serum-free media prior to activation with PAR2-AP
(SLIGRL; 20 mM). The conditioned media were collected and cleared of any cell debris by centrifuging at 5,400g for 10 min on a
microcentrifuge. Cell-derived microvesicles were then sedimented at 20,000g and 100,000g at 208C for 1 h. Microvesicles were analysed
by density gradient ultracentrifugation using a sucroseOptiPrep gradient covering an approximate range of 1.021.22 g/ml against 2
sets of DensityMarkerBeads as density markers. The samples and markers were centrifuged at 52,000g for 90 min at 208C. Following
centrifugation, aliquots (0.5 ml) were sequentially removed. The TF antigen content of the samples (A) was determined using the TF-
EIA procedure, and the thrombin generation potential of the fractions (B) was measured using a thrombin generation assay and
quantified by measuring the absorption at 410 nm (n3).
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the amount of protein in these fractions increased
with increasing RCF used during the preparative step.
In contrast, lower protein concentrations were detected
in fractions with lower relative density (B1.1 g/ml)
following preparation at 20,000g. Increasing the RCF
during the recovery of the microvesicles, particularly
when performed at 100,000g, enhanced the yield of
lower-density microvesicles derived from both MDA-
MB-231 and A375 cells.
Analysis of the relative density of TF-containing
microvesicles
Analysis of the distribution of TF antigen (Fig. 4A) and
thrombin generation potential (Fig. 4B) in the fractions
prepared from MDA-MB-231 cells alluded to the presence
of TF within the lower-density fractions (1.031.1 g/ml), in
samples prepared at 100,000g but not 20,000g. To confirm
the relative density of TF-bearing microvesicles, MDA-
MB-231 cells were transfected to overexpress TF-tGFP
–100
–50
0
50
100
150
200
1
1.02 1.04 1.06 1.08 1.1 1.14 1.16 1.18 1.2
Relative density (g/ml)
Fl
uo
re
sc
en
ce
 (5
10
 nm
)
20,000g
100,000g
–3
0
3
6
9
12
1 1.05 1.1 1.15 1.2
Relative density (g/ml)
TF
 a
nt
ig
en
 c
on
ce
nt
ra
io
n 
(ng
/m
l)
20,000g
100,000g
A)
B)
1.12
Fig. 5. Analysis of the TF antigen content and fluorescence of TF-tGFP-containing microvesicle fractions separated by density gradient
centrifugation. MDA-MB-231 cells were transfected to express the TF-tGFP hybrid protein. Cells were washed and pre-adapted to
respective serum-free media prior to activation with PAR2-AP (SLIGRL; 20 mM). The conditioned media were collected and cleared of
any cell debris by centrifuging at 5,400g for 10 min on a microcentrifuge. Cell-derived microvesicles were then sedimented at 20,000g
and 100,000g at 208C for 1 h. Microvesicles were analysed by density gradient ultracentrifugation using a sucroseOptiPrep gradient
covering an approximate range of 1.021.22 g/ml against 2 sets of DensityMarkerBeads as density markers. The samples and markers
were centrifuged at 52,000g for 90 min at 208C. Following centrifugation, aliquots (0.5 ml) were sequentially removed. The TF antigen
content of the samples was determined using the TF-EIA procedure (A). The presence of TF-tGFP protein was assessed by measuring
the fluorescence at 510 nm and subtracting the values obtained from a similar set of microvesicles but from untransfected cells (B)
(n3).
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Fig. 6. Analysis of the thrombin generation potential of microvesicle fractions separated by density gradient centrifugation. Samples of
plasma from cancer patients (n3) or pooled healthy plasma were cleared of any cell debris by centrifuging at 5,400g for 10 min on a
microcentrifuge, and microvesicles were then sedimented at 20,000g and 100,000g at 208C for 1 h. Microvesicles were then analysed by
density gradient ultracentrifugation using a sucroseOptiPrep gradient covering an approximate range of 1.021.22 g/ml against 2 sets
of DensityMarkerBeads as density markers. The samples and markers were centrifuged at 52,000g for 90 min at 208C. Following
centrifugation, aliquots (0.5 ml) were sequentially removed. Thrombin generation activity in the fractions from cancer patients (A) and
healthy plasma (B) was measured in the presence (circle) and absence of factor VII (square). (C) To highlight the TF-dependent activity,
the average of the differences between thrombin generation in the presence and absence of factor VII was calculated (n3).
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Fig. 7. (Continued).
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hybrid protein and activated to release TF-tGFP-
containing microvesicles. Microvesicles were prepared
from the conditioned media of PAR2-activated cells at
20,000g and 100,000g, and the presence of TF-tGFP
within the microvesicles was confirmed by measuring
the fluorescence emission of the samples and compared
to those isolated from the conditioned media of non-
transfected MDA-MB-231 cells. The samples were then
fractionated by sucroseOptiPrep density gradient centri-
fugation. Fractions (0.5 ml) were in turn removed from
the top of the tube, and the presence of TF was examined
by measuring the amount of TF antigen (Fig. 5A). The
presence of TF-tGFP in the fractions was also assessed
by measuring the fluorescence emission at 510 nm on
a BMG plate-reader (BMG Labtech, Aylesbury, UK)
against microvesicle fractions from non-transfected cells
as respective controls. Analysis of these microvesicle
fractions indicated the presence of TF-tGFP in lower-
density fractions (1.031.08 g/ml) in the microvesicles
isolated at 100,000g, while the samples prepared at 20,000g
did not exhibit significant levels of fluorescence (Fig. 5B).
Analysis of similar microvesicles from MDA-MB-231
cells, transfected to overexpress tGFP alone, indicated
the presence of higher-density (1.1 g/ml) fluorescent
microvesicles in the samples prepared at 20,000g and
at 100,000g, but lower-density fluorescent microvesicles
were mainly present at 100,000g (not shown).
In addition to cell-derived conditioned media, micro-
vesicles were also prepared from the plasma of cancer
patients, or from pooled healthy plasma. In each case,
the samples were fractioned using density gradient cen-
trifugation, and the thrombin generation potential was
assessed in the presence and absence of factor VII. Overall,
the thrombin generation potential was higher in samples
prepared from cancer patients (the average of 3 samples
is shown in Fig. 6A) than the fractions from healthy
plasma (Fig. 6B). Moreover, the majority of TF-dependent
thrombin generation potential was associated with the
lower-density fractions in plasma from cancer patients,
while this was almost exclusively associated with lower-
density fractions in healthy plasma. To highlight the TF-
dependent activity, the difference in thrombin generation,
in the presence and absence of factor VII, was calculated
from all samples (cancerhealthy) and plotted against the
measured relative density of the fractions. Consequently,
Fig. 6C shows significant TF-derived thrombin generation
in samples with lower relative density (1.021.06 g/ml).
Examination of pooled fractions identified to contain TF
antigen (1.031.08 g/ml), prepared from the media of
MDA-MB-231 cells, from the media of transfected
MDA-MB-231 expressing TF-tGFP or from plasma,
confirmed that these samples contained higher propor-
tions of medium to larger-sized microvesicles (77, 78 and
78%, respectively) (Fig. 7AC) compared to 49% prior to
separation (Fig. 7D), although none of the samples were
completely free of smaller-sized microvesicles. Moreover,
immuno-purified microvesicles from MDA-MB-231 and
A375 cells, isolated using a monoclonal anti-TF antibody,
exhibited a size distribution range (190400 nm) in
agreement with the above data (Fig. 7F and G).
Determination of the duration of centrifugation
required for the sedimentation of TF-containing
microvesicles
In order to determine the centrifugation time required for
the sedimentation of TF-containing microvesicles, condi-
tioned media from PAR2-activated MDA-MB-231 cells
were centrifuged at 20,000g and 100,000g for intervals
ranging from 10 to 120 min. The microvesicles were
then resuspended in PBS, and the TF antigen levels
measured. Analysis of the data indicates the progres-
sive increase in the recovery of TF-containing micro-
vesicles at 100,000g up to 60 min (Fig. 8A) but not
at 20,000g. In contrast, thrombin generation potential of
the recovered microvesicles increased with duration of
centrifugation at 20,000g but was significantly higher
at 100,000g (Fig. 8B). In addition, centrifugation of
normal plasma supplemented with TF-tGFP-containing
microvesicles, at 20,000g and 100,000g for 1 h, resulted
in the recovery of 2695.4 and 6791.1%, respectively,
Fig. 7. Nanoparticle tracking analysis (NTA) of TF-containing microvesicles (1.031.08 g/ml) separated by density gradient
centrifugation. Microvesicles were prepared from normal human plasma (A), conditioned media from MDA-MB-231 cells (B), and
conditioned media from MDA-MB-231 cells expressing TF-tGFP protein (C). The plasma and conditioned media were collected and
cleared of any cell debris by centrifuging at 5,400g on a microcentrifuge, and microvesicles sedimented at 100,000g. The microvesicles
were resuspended in PBS and were fractionated by density gradient ultracentrifugation using a sucroseOptiPrep gradient covering an
approximate density range of 1.021.22 g/ml alongside 2 sets of DensityMarkerBeads. The samples were centrifuged at 52,000g for
90 min at 208C in a SW41Ti rotor on a Beckman L8-M ultracentrifuge. Following centrifugation, aliquots (0.5 ml) were sequentially
removed and assessed for TF antigen. Samples containing TF antigen were then pooled (1.031.08 g/ml) and diluted 1:10 in PBS, and
the size of the microvesicle population was analysed by NTA using a NanoSight LM10 instrument. A control sample was prepared by
adding MDA-MB-231-derived microvesicles to the same pooled fractions from a blank density gradient centrifugation (D). A negative
control made of the pooled fractions from a blank density gradient centrifugation showed no detectable trace (E). The illustrations are
typical (n3) of the size distributions which were determined using NTA software. The total amounts of microvesicles in the samples
are not comparable. TF-containing microvesicles were immuno-purified from conditioned media of MDA-MB-231 (F) and A375 cell
lines (G). The samples were incubated with a monoclonal antibody against TF (10H10; 4 mg/ml) followed by protein A-magnetic beads.
The samples were washed with PBS and eluted in phosphate buffer containing NaCl (500 mM). The samples were analysed by NTA
against a sample treated similarly but without the antibody.
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of the original fluorescence prior to centrifugation. This
indicates that a large proportion of the microvesicles may
be recovered from plasma by centrifugation at 100,000g
for 1 h.
Influence of pre-centrifugation on the sedimentation
rate of lower-density microvesicles
The conditioned media from MDA-MB-231, A375 and
AsPC-1 cells were pre-centrifuged at 10,000g before attempt-
ing to recover the microvesicles at 20,000g and 100,000g.
Pre-centrifugation of the conditioned media at 10,000g
significantly improved the recovery of TF-containing
microvesicles at 20,000g and 100,000g (Fig. 8C).
Furthermore, while the thrombin generation potential of
the recovered microvesicles was higher in samples centri-
fuged at 100,000g compared to those isolated at 20,000g
(Fig. 8D), the differences between these 2 sets were less
significant compared to those observed with TF antigen
levels (Fig. 8C). Interestingly, pre-centrifugation also
improved the recovery of the TF-tGFP microvesicles from
plasma from 2695.4 (see above) to 5894.1%.
The density of the media prior to centrifugation was
calculated to be 1.02890.005 g/ml at 208C, and that of
plasma was measured to be 1.03090.005 g/ml (distilled
water1.00090.003 g/ml). Subsequent to centrifugation,
the density of the top and bottom 100 ml fractions were
determined to be 1.01090.032 g/ml and 1.05090.019 g/
ml, respectively for conditioned media and 1.02590.005 g/
ml and 1.05790.006 g/ml, respectively, for plasma.
The sedimentation of any particulate matter by
gravitational force may be calculated from the equation
v ¼ DqðRCFgÞd2
18g , where n is the velocity of sedimentation
(m/s), Dr is the difference between the relative density of
microvesicles and the surrounding fluid (g/ml), g is equal
to 9.8 m/s2, d is the diameter of the microvesicles (m),
and h is the viscosity of the surrounding fluid and was
assumed to be 0.001 Pas. Therefore, the sedimentation
rate is dependent on both the size and the density of the
microvesicles, as well as the density of conditioned media
or plasma. Using median values for the diameter and
density of TF-containing microvesicles, we estimated the
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Fig. 8. Analysis of the influence of the duration of centrifugation and pre-centrifugation on the recovery of TF-containing
microvesicles. Conditioned media from PAR2-activated MDA-MB-231 cells were centrifuged at 20,000g and 100,000g for intervals
ranging from 10 to 120 min. The microvesicles were then resuspended in PBS, and (A) the TF antigen levels and (B) the thrombin
generation potential of the recovered microvesicles were measured (n3, *pB0.05 vs. the amounts detected in non-centrifuged
samples). The conditioned media from AsPC-1, MDA-MB-231 and A375 cells were pre-centrifuged at 10,000g before attempting to
recover the microvesicles by centrifuging at 20,000g or 100,000g for 60 min. Similar samples were prepared from microvesicles but
without pre-centrifuging. The microvesicles were then resuspended in PBS, and (C) the TF antigen levels and (D) the thrombin
generation potential of the recovered microvesicles were measured (n3, *pB0.05 vs. the amounts detected in respective samples
without pre-centrifuging).
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rate of sedimentation of this range of microvesicles in
pre- and post-centrifuged (10,000g) media and plasma.
Using these data, the rate of sedimentation of TF-
containing microvesicles from conditioned media or
plasma, at 100,000g, was calculated to be in range
with the experimental value (50918 min for a 2.5 cm
tall centrifuge tube). Moreover, in agreement with our
experimental data, the rate of sedimentation at 20,000g
was too slow, and the required centrifugation time was
estimated to be 120 min. However, pre-centrifugation
of conditioned media or plasma at 10,000g removed the
denser microvesicles, consequently reducing the overall
relative density of the fluid and increasing the difference
between the remaining microvesicles and the surrounding
fluid (Dr) from 0.002 to 0.020 g/ml. As a result, the time
needed for the recovery of TF-containing microvesicles
was determined to be within the order of magnitude using
subsequent centrifugation at 20,000g for the majority,
if not all, of the microvesicle populations, and it explains
the observations in Fig. 8C and D.
Discussion
The procoagulant activity of microvesicles is mainly
derived from their ability to harbour TF, as well as the
high ratio of negatively charged phosphatidylserine on
the surface of the microvesicles (1). However, it is also
acknowledged that not all types of microvesicles con-
tain TF (16), or at least not at sufficient amounts to be
detectable using common measurements (17). Therefore,
discrepancies can arise as a consequence of differences
in sub-populations of microvesicles (4), and preparative
procedures used for the purification of microvesicles may
discriminate between subpopulations of microvesicles (5).
Because, during the sedimentation of microvesicles by
ultracentrifugation, the microvesicles are isolated on the
basis of size and relative density, this method is crucially
influenced by the centrifugation force, the duration of
centrifugation and the density of the supporting medium.
In this study, we employed 3 cell lines on the basis of
high levels of TF expression, as well as the ability to
release measurable amounts of TF-containing microve-
sicles. In agreement with published data (4), all recovered
microvesicles regardless of the centrifugal forces used
possessed some thrombin generation potential (Fig. 1B),
but this was not always dependent on the presence of
FVII (Fig. 1C) and could not be inhibited using an
inhibitory anti-TF antibody (Fig. 1F). However, assess-
ment of TF antigen content of the recovered microvesicles
indicates that high RCF values (ideally, 100,000g)
improve the sedimentation of TF-containing microvesi-
cles (Fig. 1). In agreement, these microvesicles also
possessed the highest factor VIIadependent thrombin
and factor Xa generation potential (Fig. 1BF). Analysis
of the size of the recovered microvesicles indicated
a general pattern in which medium-sized microvesicles
were sedimented at lower centrifugal forces (20,000g), fol-
lowed by smaller-sized microvesicles at 50,00075,000g,
and the larger microvesicles were mostly recoverable
at 100,000g (Fig. 2). These data are in agreement with
previously published studies on determination of size of
platelet-derived microvesicles which show 4 separate sub-
populations of microvesicles (6). The study by Dean et al.
(6) indicates that larger microvesicles contain membrane
proteins, whereas the contents of the smaller-sized micro-
vesicle classes originated from within the cell compart-
ments. In addition, filtration of the microvesicle samples
has been shown to remove the major proportion of TF
antigen and activity in the samples (18). However, the
authors reported a larger drop in TF activity compared to
TF antigen, which may suggest an exchange of lipids.
Therefore, as a parallel, the association of TF with the
larger-sized microvesicles is in line with the notion that
the formation of these microvesicles is initiated from the
lipid rafts on the cell surface (19,20).
Since the sedimentation rate is dependent on both the
size and relative density of the microvesicles, it would then
be logical to assume that the larger-sized microvesicles
prepared in our study ought to have lower relative density
compared to the medium- and smaller-sized microvesicles.
Interestingly, the lower-density fractions obtained at
100,000g were shown to contain measurable levels of TF
antigen (Figs. 4A and 5A) and TF activity (Fig. 4B), as
well as possessing fluorescence intensity arising from the
TF-tGFP hybrid protein (Fig. 5B). Finally, examination of
the relative density of microvesicle samples obtained by
ultracentrifugation of patient and normal plasma also
indicated the presence of TF in the lower-density fractions
(Fig. 6A and B). Moreover, the lower density fractions
containing the TF also exhibited higher proportions of
larger-diameter microvesicles (Supplementary Fig. 5).
Previous analysis of the protein and lipid content of the
platelet-derived microvesicles also indicates that the highest
lipidprotein ratio may be associated with the larger
microvesicles, with the medium-sized microvesicles having
the lowest ratio (6). This in turn suggests that the larger-
sized microvesicles have the lowest, while the medium-
sized microvesicles possess the highest, relative densities,
and it is in agreement with our findings. Furthermore, lipid
rafts have been shown to be regions of low relative density,
arising from the higher lipidprotein ratios compared to
the rest of the cell membrane (21,22). Therefore, this is also
in agreement with the concept of formation of micro-
vesicles from distinct regions within the surface of the cells.
However, future morphological (e.g. electron microscopy)
studies are required to fully characterize the vesicular
nature of the low-density TF-positive microvesicles.
A time course of sedimentation of TF-containing
microvesicles showed that the sedimentation of these
microvesicles was time dependent as well as RCF depen-
dent (Fig. 8A and B). Moreover, the removal of the denser
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microvesicles by pre-centrifugation at 10,000g permitted
the partial recovery of TF-containing microvesicles at
20,000g but did not present a huge advantage in the
recovery at 100,000g in most cases (Fig. 8C and D).
The understanding of physical and compositional
properties of procoagulant microvesicles is crucial for the
understanding of the biological functions of these parti-
cles. As far as we are aware, this is the first study in which
an attempt has been made to characterize the physical
properties of TF-containing microvesicles and to discern
these from the population of microvesicles released by
cells. In summary, our studies indicate that TF mainly
resides within lower-density microvesicles (1.031.08 g/ml)
with diameters ranging between 200 and 350 nm. Further-
more, we have established some guidelines for the recovery
of these microvesicles from both conditioned media and
plasma, but further refinement would be essential.
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